Epidemiology of End-Stage Renal Failure: The Burden of Kidney Diseases to Global Health

Kidney Transplantation, Bioengineering, and Regeneration: Kidney Transplantation in the Regenerative Medicine Era

Volumn , Issue , 2017, Pages 5-11

  Trillini, Matias ^a   Perico, Norberto ^a   Remuzzi, Giuseppe ^a,b,c  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b Unit of Nephrology   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Chronic kidney diseases; End stage renal failure; Epidemiology; Incidence; Noncommunicable diseases; Prevalence

Indexed keywords

EPIDEMIOLOGY; HEALTH RISKS; PATIENT TREATMENT;

CHRONIC KIDNEY DISEASE; INCIDENCE; NON-COMMUNICABLE DISEASE; PREVALENCE; RENAL FAILURE;

DISEASES;

EID: 85032473753     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-801734-0.00001-1     Document Type: Chapter

References (88)

1. Schlipköter U., Flahault A. Communicable diseases: achievements and challenges for public health. Public Health Rev 2010, 32:90-119.
2. Cohen M.L. Changing patterns of infectious disease. Nature 2000, 406(6797):762-767.
3. Murray C.J.L., Lopez A.D. Measuring the global burden of disease. N Engl J Med 2013, 369(5):448-457.
4. Gwatkin D.R., Guillot M., Heuveline P. The burden of disease among the global poor. Lancet 1999, 354(9178):586-589.
5. Perico N., Remuzzi G. Chronic kidney disease: a research and public health priority. Nephrol Dial Transplant 2012, 27(Suppl. 3):iii19-iii26.
6. Naghavi M., Wang H., Lozano R., et al. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015, 385(9963):117-171.
7. Beaglehole R., Bonita R., Alleyne G., et al. UN High-level meeting on non-communicable diseases: addressing four questions. Lancet 2011, 378(9789):449-455.
8. Alwan A. Global status report on noncommunicable diseases 2010, World Health Organization, Available from: http://www.who.int/nmh/publications/ncd_report_full_en.pdf.
9. Global health and aging 2011. World Health Organization. Available from:. http://www.who.int/ageing/publications/global_health/en/.
10. Roura L.C., Arulkumaran S.S. Facing the noncommunicable disease (NCD) global epidemic - The battle of prevention starts in utero - The FIGO challenge. Best Pract Res Clin Obstet Gynaecol 2015, 29(1):5-14.
11. Global action plan for the prevention and control of noncommunicable diseases 2013-2020. World Health Organization. Available from:. http://apps.who.int/iris/bitstream/10665/94384/1/9789241506236_eng.pdf.
12. Mathers C.D., Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006, 3(11):e442.
13. Smith S.C., Collins A., Ferrari R., et al. Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke). Glob Heart 2012, 7:297-305.
14. Roth G.A., Forouzanfar M.H., Moran A.E., et al. Demographic and epidemiologic drivers of global cardiovascular mortality. N Engl J Med 2015, 372(14):1333-1341.
15. Fitzmaurice C., Dicker D., Pain A., et al. The global burden of cancer 2013. JAMA Oncol 2015, 1(4):505-527.
16. Popat K., McQueen K., Feeley T.W. The global burden of cancer. Best Pract Res Clin Anaesthesiol 2013, 27(4):399-408.
17. Ferkol T., Schraufnagel D. The global burden of respiratory disease. Ann Am Thorac Soc 2014, 11(3):404-406.
18. Pauwels R.A., Rabe K.F. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004, 364(9434):613-620.
19. Burney P., Jarvis D., Perez-Padilla R. The global burden of chronic respiratory disease in adults. Int J Tuberc Lung Dis 2015, 19(1):10-20.
20. Guariguata L., Whiting D.R., Hambleton I., Beagley J., Linnenkamp U., Shaw J.E. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 2014, 103(2):137-149.
21. Hu F.B., Satija A., Manson J.E. Curbing the diabetes pandemic: the need for global policy solutions. JAMA 2015, 313(23):2319-2320.
22. Vos T., Barber R.M., Bell B., et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015, 386(9995):743-800.
23. Kaveeshwar S.A., Cornwall J. The current state of diabetes mellitus in India. Australas Med J 2014, 7(1):45-48.
24. Wild S., Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes estimates for the year 2000 and projections for 2030. Diab Care 2004, 27(5):1047-1053.
25. The growing danger of non-communicable diseases: acting now to reverse course. Conference Edition 2011. The World Bank. Available from:. http://siteresources.worldbank.org/HEALTHNUTRITIONANDPOPULATION/Resources/Peer-Reviewed-Publications/WBDeepeningCrisis.pdf.
26. Alleyne G., Binagwaho A., Haines A., et al. Embedding non-communicable diseases in the post-2015 development agenda. Lancet 2013, 381(9866):566-574.
27. Beaglehole R., Bonita R., Horton R., et al. Priority actions for the non-communicable disease crisis. Lancet 2011, 377(9775):1438-1447.
28. Lopez A.D., Williams T.N., Levin A., et al. Remembering the forgotten non-communicable diseases. BMC Med 2014, 12(1):200.
29. Couser W.G., Remuzzi G., Mendis S., Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int 2011, 80(12):1258-1270.
30. Roderick P. Epidemiology of end-stage renal disease. Clin Med 2002, 2(3):200-204.
31. Anand S., Bitton A., Gaziano T. The gap between estimated incidence of end-stage renal disease and use of therapy. PloS One 2013, 8(8):e72860.
32. Levey A.S., Coresh J. Chronic kidney disease. Lancet 2012, 379(9811):165-180.
33. Remuzzi G., Benigni A., Finkelstein F.O., et al. Kidney failure: aims for the next 10 years and barriers to success. Lancet 2013, 382(9889):353-362.
34. Caskey F.J., Kramer A., Elliott R.F., et al. Global variation in renal replacement therapy for end-stage renal disease. Nephrol Dial Transplant 2011, 26(8):2604-2610.
35. Levin A., Stevens P.E. Early detection of CKD: the benefits, limitations and effects on prognosis. Nat Rev Nephrol 2011, 7(8):446-457.
36. Jha V., Wang A.Y.-M., Wang H. The impact of CKD identification in large countries: the burden of illness. Nephrol Dial Transplant 2012, 27(Suppl. 3):iii32-iii38.
37. Jha V., Garcia-Garcia G., Iseki K., et al. Chronic kidney disease: global dimension and perspectives. Lancet 2013, 382(9888):260-272.
38. Brück K., Jager K.J., Dounousi E., et al. Methodology used in studies reporting chronic kidney disease prevalence: a systematic literature review. Nephrol Dial Transplant 2015, 30(Suppl. 4):iv6-16.
39. Perico N., Remuzzi G. Need for chronic kidney disease prevention programs in disadvantaged populations. Clin Nephrology 2015, 83(7 Suppl. 1):42-48.
40. El Nahas A.M., Bello A.K. Chronic kidney disease: the global challenge. Lancet 2005, 365(9456):331-340.
41. Levey A.S., Atkins R., Coresh J., et al. Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int 2007, 72(3):247-259.
42. Zhang Q.-L., Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health 2008, 8(1):117. doi:10.1186/1471-2458-8-117.
43. Levey A.S., Andreoli S.P., DuBose T., Provenzano R., Collins A.J. Chronic kidney disease: common, harmful and treatable-World Kidney Day 2007. Am J Nephrol 2007, 27(1):108-112.
44. Cravedi P., Sharma S.K., Bravo R.F., et al. Preventing renal and cardiovascular risk by renal function assessment: insights from a cross-sectional study in low-income countries and the USA. BMJ Open 2012, 2(5):e001357.
45. Rhee C.M., Kovesdy C.P. Spotlight on CKD deaths-increasing mortality worldwide. Nat Rev Nephrol 2015, 11(4):199-200.
46. Zhang L., Wang F., Wang L., et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 2012, 379(9818):815-822.
47. United States Renal Data System USRDS annual data report: epidemiology of kidney disease in the United States 2015, National Institutes of Health, Available from: www.usrds.org.
48. Stenvinkel P. Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease. J Intern Med 2010, 268(5):456-467.
49. Thomas B., Wulf S., Bikbov B., et al. Maintenance dialysis throughout the World in Years 1990 and 2010. J Am Soc Nephrol 2015, 26:2621-2633.
50. Beard J.R., Officer A., de Carvalho I.A., et al. The World report on ageing and health: a policy framework for healthy ageing. Lancet 2016, 387:2145-2154.
51. Lin M.-Y., Chiu Y.-W., Lee C.-H., et al. Factors associated with CKD in the elderly and nonelderly population. Clin J Am Soc Nephrol 2013, 8:33-40.
52. Glassock R.J., Rule A.D. The implications of anatomical and functional changes of the aging kidney: with an emphasis on the glomeruli. Kidney Int 2012, 82(3):270-277.
53. Zürbig P., Decramer S., Dakna M., et al. The human urinary proteome reveals high similarity between kidney aging and chronic kidney disease. Proteomics 2009, 9(8):2108-2117.
54. Glassock R.J., Oreopoulos D.G. Aging and chronic kidney disease. Nephron Clin Pract 2011, 119(Suppl. 1):c1. doi:10.1159/000328007.
55. NHANES. Age-Adjusted Prevalence of CKD Stages 1-4 by Gender 1999-2012. Available from:. http://www.cdc.gov/diabetes/programs/initiatives/kidney.html.
56. Gambaro G., Yabarek T., Graziani M.S., et al. Prevalence of CKD in northeastern Italy: results of the INCIPE study and comparison with NHANES. Clin J Am Soc Nephrol 2010, 5:1946-1953.
57. van Blijderveen J.C., Straus S.M., Zietse R., Stricker B.H., Sturkenboom M.C., Verhamme K.M. A population-based study on the prevalence and incidence of chronic kidney disease in the Netherlands. Int Urol Nephrol 2014, 46(3):583-592.
58. Juutilainen A., Kastarinen H., Antikainen R., et al. Comparison of the MDRD Study and the CKD-EPI Study equations in evaluating trends of estimated kidney function at population level: findings from the National FINRISK Study. Nephrol Dial Transplant 2012, 27(8):3210-3217.
59. Arora P., Vasa P., Brenner D., et al. Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey. CMAJ 2013, 185:E417-E423.
60. Perico N., Bravo R.F., De Leon F.R., Remuzzi G. Screening for chronic kidney disease in emerging countries: feasibility and hurdles. Nephrol Dial Transplant 2009, 24(5):1355-1358.
61. Ingsathit A., Thakkinstian A., Chaiprasert A., et al. Prevalence and risk factors of chronic kidney disease in the Thai adult population: Thai SEEK study. Nephrol Dial Transplant 2010, 25(5):1567-1575.
62. Arogundade F.A., Barsoum R.S. CKD prevention in Sub-Saharan Africa: a call for governmental, nongovernmental, and community support. Am J Kidney Dis 2008, 51(3):515-523.
63. Sumaili E.K., Krzesinski J.-M., Zinga C.V., et al. Prevalence of chronic kidney disease in Kinshasa: results of a pilot study from the Democratic Republic of Congo. Nephrol Dial Transplant 2009, 24(1):117-122.
64. Tonelli M., Riella M. Chronic kidney disease and the aging population. Nephrol Dial Transplant 2014, 29(2):221-224.
65. Dalrymple L.S., Katz R., Kestenbaum B., et al. Chronic kidney disease and the risk of end-stage renal disease versus death. J Gen Intern Med 2011, 26(4):379-385.
66. Moynihan R., Glassock R., Doust J. Chronic kidney disease controversy: how expanding definitions are unnecessarily labelling many people as diseased. BMJ 2013, 347:f4298.
67. O'Hare A.M., Choi A.I., Bertenthal D., et al. Age affects outcomes in chronic kidney disease. J Am Soc Nephrol 2007, 18(10):2758-2765.
68. Hallan S.I., Matsushita K., Sang Y., et al. Age and association of kidney measures with mortality and end-stage renal disease. JAMA 2012, 308(22):2349-2360.
69. Iseki K. Gender differences in chronic kidney disease. Kidney Int 2008, 74(4):415-417.
70. Halbesma N., Brantsma A.H., Bakker S.J., et al. Gender differences in predictors of the decline of renal function in the general population. Kidney Int 2008, 74(4):505-512.
71. Carrero J.J. Gender differences in chronic kidney disease: underpinnings and therapeutic implications. Kidney Blood Press Res 2010, 33(5):383-392.
72. Eriksen B.O., Tomtum J., Ingebretsen O.C. Predictors of declining glomerular filtration rate in a population-based chronic kidney disease cohort. Nephron Clin Pract 2010, 115(1):c41-c50.
73. Neugarten J., Acharya A., Silbiger S.R. Effect of gender on the progression of nondiabetic renal disease a meta-analysis. J Am Soc Nephrol 2000, 11(2):319-329.
74. Silbiger S., Neugarten J. Gender and human chronic renal disease. Gend Med 2008, 5:S3-S10.
75. Norris K., Nissenson A.R. Race, gender, and socioeconomic disparities in CKD in the United States. J Am Soc Nephrol 2008, 19(7):1261-1270.
76. Feehally J. Ethnicity and renal disease. Kidney Int 2005, 68(1):414-424.
77. Harawa N.T., Norris K.C. The role of ethnic variation and CKD. Clin J Am Soc Nephrol 2015, 10:1708-1710.
78. Saran R., Li Y., Robinson B., et al. US Renal Data System 2015 Annual Data Report: epidemiology of kidney disease in the United States. Am J Kidney Dis 2016, 67(3 Suppl. 1):S1-S434.
79. Palmer A.T., Lewis J. Racial differences in chronic kidney disease (CKD) and end-stage renal disease (ESRD) in the United States: a social and economic dilemma. Clin Nephrol 2010, 74:S72-S77.
80. Collins J.F. Kidney disease in Maori and Pacific people in New Zealand. Clin Nephrol 2010, 74(Suppl.1):s61-s65.
81. Sabanayagam C., Lim S.C., Wong T.Y., Lee J., Shankar A., Tai E.S. Ethnic disparities in prevalence and impact of risk factors of chronic kidney disease. Nephrol Dial Transplant 2010, 25(8):2564-2570.
82. Nicholas S.B., Kalantar-Zadeh K., Norris K.C. Socioeconomic disparities in chronic kidney disease. Adv Chronic Kidney Dis 2015, 22(1):6-15.
83. Swanepoel C.R., Wearne N., Okpechi I.G. Nephrology in Africa-not yet uhuru. Nat Rev Nephrol 2013, 9(10):610-622.
84. Stanifer J.W., Jing B., Tolan S., et al. The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health 2014, 2(3):e174-e181.
85. Hossain M.P., Goyder E.C., Rigby J.E., El Nahas M. CKD and poverty: a growing global challenge. Am J Kidney Dis 2009, 53(1):166-174.
86. García-García G., Jha V. World Kidney Day 2015: CKD in disadvantaged populations. Am J Kidney Dis 2015, 65(3):349-353.
87. Young B.A. The interaction of race, poverty, and CKD. Am J Kidney Dis 2010, 55(6):977-980.
88. Patzer R.E., McClellan W.M. Influence of race, ethnicity and socioeconomic status on kidney disease. Nat Rev Nephrol 2012, 8(9):533-541.